Kiromic BioPharma, Inc. Securities Litigation Online Claim Form

This form allows you to file your claim online securely through our website.

Please note that your brokerage documents such as trade confirmations and monthly statements must be uploaded in order to complete this submission.

1. General Instructions
Please read this important information about the case. It provides important details you should understand before you file your claim.

2. Claimant Identification/Information
Please enter your current contact information to assist us in identifying your claim and contacting you for additional information and updates. We recommend you turn off auto-fill settings in your browser to ensure incorrect information is not added by mistake. You will receive a confirmation email that we received your claim at the email address you provide. Double check the information before you click Next as you will not have the opportunity to review it again prior to submitting.

3. Schedule of Transactions
Please read the instructions carefully and enter your relevant transactions. You need to ensure that your number of shares in beginning holdings plus purchases/acquisitions minus sales and minus ending holdings equals zero. This is to ensure that all relevant transactions are accounted for. The form will not allow you to continue until all outstanding shares are accounted for.

4. Documentation
Please drag and drop your files or click select files and choose the files that you will provide as proof of your transactions and holdings. Trade confirmations and monthly statements from your respective brokerage firm are usually the best documents to use as proof. Please note that when the file upload completes, the file name will be listed below the upload box. You can click the trash can icon to remove the file if it was added in error.

5. Certification
Please read the Certification. By typing your name and date in these fields, you are signing the document and certifying that everything is true, correct and complete.

After you click the submit button
Within a few minutes of submitting your claim, you will receive a confirmation email from us that contains your Form ID along with the information you submitted. If you need to make any amendments to your claim, please reference the Form ID you received. Please check your spam folder if you did not receive the email confirmation in your inbox.

GENERAL INSTRUCTIONS

Deadline for Submission: December 14, 2026

IF YOU PURCHASED OR OTHERWISE ACQUIRED KIROMIC BIOPHARMA INC. (“KIROMIC”) COMMON STOCK PURSUANT AND/OR TRACEABLE TO THE OFFERING DOCUMENTS AND/OR KIROMIC COMMON STOCK BETWEEN JUNE 25, 2021 AND FEBRUARY 2, 2022, BOTH DATES INCLUSIVE, AND SUBJECT TO 15 U.S.C. § 78U-4(E)(1) (THE “CLASS PERIOD”) YOU ARE A “SETTLEMENT CLASS MEMBER” AND YOU MAY BE ENTITLED TO SHARE IN THE SETTLEMENT PROCEEDS. (EXCLUDED FROM THE SETTLEMENT CLASS ARE: (I) THE DEFENDANTS; (II) THE OFFICERS AND DIRECTORS OF THE COMPANY AT ALL RELEVANT TIMES; (III) MEMBERS OF ANY INDIVIDUAL DEFENDANT’S IMMEDIATE FAMILIES; (IV) ANY ENTITY IN WHICH ANY OF THE DEFENDANTS HAVE OR HAD A CONTROLLING INTEREST OR WHICH IS RELATED TO OR AFFILIATED WITH ANY OF THE DEFENDANTS; (V) THE LEGAL REPRESENTATIVES, HEIRS, SUCCESSORS, AND ASSIGNS OF SUCH EXCLUDED PERSONS; (VI) THOSE WHO PURCHASED OR OTHERWISE ACQUIRED KIROMIC COMMON STOCK ON FOREIGN EXCHANGES, IN ACCORDANCE WITH THE UNITED STATES SUPREME COURT’S DECISION IN MORRISON V. NAT’L AUSTRALIA BANK LTD., 561 U.S. 247, 267 (2010); (VII) THE PLAINTIFFS IN SABBY VOLATILITY WARRANT MASTER FUND LTD., ET AL. V. KIROMIC BIOPHARMA, INC., NO. 22-CV-1927(AT) (S.D.N.Y.), AND ANY CLAIMS THAT WERE OR COULD HAVE BEEN FILED OR CONSOLIDATED THEREWITH AND (VIII) ANY PERSONS WHO EXCLUDE THEMSELVES BY SUBMITTING A REQUEST FOR EXCLUSION THAT IS ACCEPTED BY THE COURT.)

IF YOU ARE A SETTLEMENT CLASS MEMBER, YOU MUST COMPLETE AND SUBMIT THIS PROOF OF CLAIM AND RELEASE FORM (“PROOF OF Claim”) IN ORDER TO BE ELIGIBLE FOR ANY SETTLEMENT BENEFITS. YOU CAN COMPLETE AND SUBMIT THE ELECTRONIC VERSION OF THIS CLAIM FORM BY 11:59 P.M. EST ON DECEMBER 14, 2026 BY CLICKING NEXT BELOW AND FOLLOWING ALL THE INSTRUCTIONS.

IF YOU DO NOT COMPLETE AND SUBMIT AN ELECTRONIC VERSION OF THIS PROOF OF CLAIM, YOU MUST COMPLETE AND SIGN THIS PROOF OF CLAIM AND MAIL IT BY FIRST CLASS MAIL, POSTMARKED NO LATER THAN DECEMBER 14, 2026 TO STRATEGIC CLAIMS SERVICES, THE CLAIMS ADMINISTRATOR, AT THE FOLLOWING ADDRESS:

1. 1. I (we) purchased or otherwise acquired Kiromic BioPharma Inc. (“BioPharma”) common stock during the Class Period. (Do not submit this Proof of Claim and Release Form if you did not purchase Kiromic common stock during the Class Period.)


2. 2. By submitting this Proof of Claim, I (we) state that I (we) believe in good faith that I am (we are) a Settlement Class Member(s) as defined above and in the Notice of Pendency and Proposed Settlement of Class Action, Fairness Hearing and Class Members’ Rights (the “Notice”), or am (are) acting for such person(s); that I am (we are) not a Defendant in the Action or anyone excluded from the Settlement Class; that I (we) have read and understand the Notice; that I (we) believe that I am (we are) entitled to receive a share of the Net Settlement Fund, as defined in the Notice; that I (we) elect to participate in the proposed Settlement described in the Notice; and that I (we) have not filed a request for exclusion. (If you are acting in a representative capacity on behalf of a Settlement Class Member [e.g., as an executor, administrator, trustee, or other representative], you must submit evidence of your current authority to act on behalf of that Settlement Class Member. Such evidence would include, for example, letters testamentary, letters of administration, or a copy of the trust documents.)


3. 3. I (we) consent to the jurisdiction of the Court with respect to all questions concerning the validity of this Proof of Claim. I (we) understand and agree that my (our) claim may be subject to investigation and discovery under the Federal Rules of Civil Procedure, provided that such investigation and discovery shall be limited to my (our) status as a Settlement Class Member(s) and the validity and amount of my (our) claim. No discovery shall be allowed on the merits of the Action or Settlement in connection with processing of the Proof of Claim.


4. 4. I (we) have set forth where requested all relevant information with respect to each purchase or acquisition of Kiromic common stock, and each sale, if any, of such common stock. I (we) agree to furnish additional information to the Claims Administrator to support this claim if requested to do so.


5. 5. I (we) have attached photocopies of the stockbroker’s confirmation slips, stockbroker’s statements, or other documents evidencing each purchase and sale of Kiromic common stock listed in support of my (our) claim. If any such documents are not in your possession, please obtain a copy or equivalent documents from your broker or tax advisor because these documents are necessary to prove and process your claim. YOUR FAILURE TO SUBMIT COPIES OF OFFICIAL DOCUMENTS EVIDENCING YOUR PURCHASES AND/OR SALES OF KIROMIC COMMON STOCK WILL CAUSE THE CLAIMS ADMINISTRATOR TO REJECT YOUR CLAIM.


6. 6. I (we) understand that the information contained in this Proof of Claim is subject to such verification as the Claims Administrator may request or as the Court may direct, and I (we) agree to cooperate in any such verification. (The information requested herein is designed to provide the minimum amount of information necessary to process most simple claims. The Claims Administrator may request additional information as required to efficiently and reliably calculate your Recognized Loss. In some cases, the Claims Administrator may condition acceptance of the claim based upon the production of additional information, including, where applicable, information concerning transactions in any derivatives securities such as options.)


7. 7. Upon the occurrence of the Court’s final approval of the Settlement, as detailed in the Notice, I (we) agree and acknowledge that my (our) signature(s) hereto shall effect and constitute a full and complete release, remise and discharge by me (us) and my (our) spouses, heirs, joint tenants, tenants in common, beneficiaries, executors, administrators, predecessors, successors, attorneys, insurers and assigns (or, if I am (we are) submitting this Proof of Claim on behalf of a corporation, a partnership, estate or one or more other persons, by it, him, her or them, and by its, his, her or their heirs, executors, administrators, predecessors, successors, and assigns) of each of the “Released Parties” of all “Released Claims,” as those terms are defined in the Stipulation of Settlement, dated March 5, 2026 (“Stipulation”).


8. 8. Upon the occurrence of the Court’s final approval of the Settlement, as detailed in the Notice, I (we) agree and acknowledge that my (our) signature(s) hereto shall effect and constitute a covenant by me (us) and my (our) heirs, joint tenants, tenants in common, beneficiaries, executors, administrators, predecessors, successors, attorneys, insurers and assigns (or, if I am (we are) submitting this Proof of Claim on behalf of a corporation, a partnership, estate or one or more other persons, by it, him, her or them, and by its, his, her or their heirs, executors, administrators, predecessors, successors, and assigns) to permanently refrain from prosecuting or attempting to prosecute any Released Claims against any of the Released Parties.


9. 9. “Released Parties” has the meaning laid out in the Stipulation.


10. 10. “Released Claims” has the meaning laid out in the Stipulation.


11. 11. “Unknown Claims” has the meaning laid out in the Stipulation.


12. 12. I (We) acknowledge that the inclusion of “Unknown Claims” in the definition of claims released pursuant to the Stipulation was separately bargained for and is a material element of the Settlement of which this release is a part.


13. 13. NOTICE REGARDING INSTITUTIONAL FILERS: Representatives with authority to file on behalf of (a) accounts of multiple Settlement Class Members and/or (b) institutional accounts with large numbers of transactions (“Representative Filers”) must submit information regarding their transactions in an electronic spreadsheet format. If you are a Representative Filer, you must contact the Claims Administrator at efile@strategicclaims.net or visit their website at www.strategicclaims.net/Kiromic/ to obtain the required file layout. Claims which are not submitted in electronic spreadsheet format and in accordance with the Claims Administrator’s instructions may be subject to rejection. All Representative Filers MUST also submit a manually signed Proof of Claim, as well as proof of authority to file (see Item 2 of the Claimant’s Statement), along with the electronic spreadsheet format. No claims submitted in electronic spreadsheet format will be considered to have been properly submitted unless the Claims Administrator issues to the Claimant a written acknowledgment of receipt and acceptance of electronically submitted data.


14. 14. NOTICE REGARDING ONLINE FILING: Claimants who are not Representative Filers may submit their claims online using this electronic version of the Proof of Claim by clicking Next below and following all the instructions. If you are not acting as a Representative Filer, you do not need to contact the Claims Administrator prior to filing; you will receive an automated e-mail confirming receipt once your Proof of Claim has been submitted. If you are unsure if you should submit your claim as a Representative Filer, please contact the Claims Administrator at info@strategicclaims.net or (866) 274-4004. If you are not a Representative Filer, but your claim contains a large number of transactions, the Claims Administrator may request that you also submit an electronic spreadsheet showing your transactions to accompany your Proof of Claim.